1. Home
  2. III vs PMI Comparison

III vs PMI Comparison

Compare III & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Information Services Group Inc.

III

Information Services Group Inc.

HOLD

Current Price

$4.56

Market Cap

250.9M

ML Signal

HOLD

PMI

Picard Medical Inc.

N/A

Current Price

$1.12

Market Cap

202.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
III
PMI
Founded
2006
1981
Country
United States
United States
Employees
1300
N/A
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
250.9M
202.7M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
III
PMI
Price
$4.56
$1.12
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
313.6K
1.6M
Earning Date
06-09-2026
01-01-0001
Dividend Yield
3.78%
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$192,745,000.00
N/A
Revenue This Year
$4.62
N/A
Revenue Next Year
$5.22
N/A
P/E Ratio
$36.77
N/A
Revenue Growth
4.51
N/A
52 Week Low
$3.17
$0.96
52 Week High
$6.45
$13.68

Technical Indicators

Market Signals
Indicator
III
PMI
Relative Strength Index (RSI) 36.78 36.04
Support Level $4.48 N/A
Resistance Level $5.05 $2.52
Average True Range (ATR) 0.20 0.11
MACD 0.03 -0.00
Stochastic Oscillator 25.00 21.74

Price Performance

Historical Comparison
III
PMI

About III Information Services Group Inc.

Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.

About PMI Picard Medical Inc.

Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.

Share on Social Networks: